Cybersecurity Threats & Pharma
PharmExec
JANUARY 11, 2023
The steps companies can take now to better protect themselves and their data.
PharmExec
JANUARY 11, 2023
The steps companies can take now to better protect themselves and their data.
Pharmaceutical Technology
JUNE 5, 2023
Earlier this year, Sun Pharmaceutical Industries , one of India’s largest generic drug producers, reported a major cybersecurity breach , impacting its business operations. A ransomware group later claimed responsibility for the incident, which was one of several high-profile cybersecurity breaches in India over the past three years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Impetus Digital
MARCH 25, 2024
Data breaches can happen in any industry, and unfortunately, pharmaceutical companies aren’t immune to this threat. With a handful of big names responsible for dispensing billions of prescriptions across the US each year, Pharma companies are the keepers of vast amounts of data and, as such, are attractive targets for cybercriminals.
PharmExec
NOVEMBER 16, 2022
Learn about the evolving cyber-threat landscape affecting the pharmaceutical industry and the recommended approach to addressing those threats.
Impetus Digital
JANUARY 11, 2024
But with thousands of private and confidential records being stored digitally, the pharma industry can unfortunately fall victim to cybercrime, just as any other online business can. Here, we explore three cybersecurity challenges facing the pharma industry. To reduce the risk of a phishing attack, employee training is key.
Pharma Marketing Network
OCTOBER 26, 2020
The pharmaceutical industry deals with copious amounts of personal data, which means that adequate data protection and cybersecurity are non-negotiable. There are two sides of the data protection issue facing the pharma industry. Data protection is especially significant for the pharma industry because of identifiable data.
Pharmaceutical Technology
OCTOBER 27, 2022
This could have wide-reaching effects on emerging pharmaceutical markets such as China, which are seeking to acquire innovative pharma manufacturing expertise in the US. After a foreign company has filed a notice of its plan to invest in the US, CFIUS initiates a 30-day threat assessment to identify national security concerns.
Let's personalize your content